Pieris Pharmaceuticals Price on July 23, 2024

PIRSDelisted Stock  USD 13.60  1.41  9.39%   
If you're considering investing in Pieris Stock, it is important to understand the factors that can impact its price. As of today, the current price of Pieris Pharmaceuticals stands at 13.60, as last reported on the 28th of December, with the highest price reaching 15.35 and the lowest price hitting 13.26 during the day. Pieris Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of -0.11, which implies the firm had a -0.11% return per unit of risk over the last 3 months. Pieris Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Pieris Pharmaceuticals' Variance of 7.53, risk adjusted performance of (0.08), and Coefficient Of Variation of (911.59) to confirm the risk estimate we provide.
  
Pieris Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.113

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsPIRS

Estimated Market Risk

 2.82
  actual daily
25
75% of assets are more volatile

Expected Return

 -0.32
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.11
  actual daily
0
Most of other assets perform better
Based on monthly moving average Pieris Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Pieris Pharmaceuticals by adding Pieris Pharmaceuticals to a well-diversified portfolio.

Pieris Pharmaceuticals Valuation on July 23, 2024

It is possible to determine the worth of Pieris Pharmaceuticals on a given historical date. On July 23, 2024 Pieris was worth 7.41 at the beginning of the trading date compared to the closed value of 7.98. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Pieris Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Pieris Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Pieris Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Pieris Pharmaceuticals' related companies.
 Open High Low Close Volume
  7.53    7.83    7.30    7.48    21,053  
07/23/2024
  7.41    7.98    7.34    7.98    42,063  
  13.19    17.45    12.63    15.05    5,841,515  
Backtest Pieris Pharmaceuticals  |  Pieris Pharmaceuticals History  |  Pieris Pharmaceuticals Valuation   PreviousNext  
Open Value
7.41
7.98
Closing Value
15.86
Upside

Pieris Pharmaceuticals Trading Date Momentum on July 23, 2024

On July 24 2024 Pieris Pharmaceuticals was traded for  15.05  at the closing time. The top price for the day was 17.45  and the lowest listed price was  12.63 . The trading volume for the day was 5.8 M. The trading history from July 24, 2024 was a factor to the next trading day price appreciation. The trading delta at closing time against the next closing price was 88.60% . The trading delta at closing time against the current closing price is 108.02% .

Pieris Pharmaceuticals Fundamentals Correlations and Trends

By evaluating Pieris Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Pieris Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Pieris financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Pieris Pharmaceuticals Stock history

Pieris Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Pieris is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Pieris Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Pieris Pharmaceuticals stock prices may prove useful in developing a viable investing in Pieris Pharmaceuticals
Pieris Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops anticalin-based drugs. Pieris Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Boston, Massachusetts. Pieris Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 124 people.

Pieris Pharmaceuticals Stock Technical Analysis

Pieris Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Pieris Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Pieris Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Pieris Pharmaceuticals Period Price Range

Low
December 28, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Pieris Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Pieris Pharmaceuticals December 28, 2024 Market Strength

Market strength indicators help investors to evaluate how Pieris Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Pieris Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Pieris Pharmaceuticals stock market strength indicators, traders can identify Pieris Pharmaceuticals entry and exit signals to maximize returns

Pieris Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Pieris Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Pieris Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Pieris to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Consideration for investing in Pieris Stock

If you are still planning to invest in Pieris Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Pieris Pharmaceuticals' history and understand the potential risks before investing.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Equity Valuation
Check real value of public entities based on technical and fundamental data